vs
GE医疗（CCRN）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是ROGERS CORP的1.2倍（$236.8M vs $200.5M），ROGERS CORP净利率更高（2.2% vs -35.0%，领先37.3%），ROGERS CORP同比增速更快（5.2% vs -23.6%），GE医疗自由现金流更多（$16.1M vs $1.1M），过去两年ROGERS CORP的营收复合增速更高（-3.3% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
CCRN vs ROG — 直观对比
营收规模更大
CCRN
是对方的1.2倍
$200.5M
营收增速更快
ROG
高出28.9%
-23.6%
净利率更高
ROG
高出37.3%
-35.0%
自由现金流更多
CCRN
多$15.0M
$1.1M
两年增速更快
ROG
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $200.5M |
| 净利润 | $-82.9M | $4.5M |
| 毛利率 | — | 32.2% |
| 营业利润率 | -30.2% | — |
| 净利率 | -35.0% | 2.2% |
| 营收同比 | -23.6% | 5.2% |
| 净利润同比 | -2109.7% | 421.4% |
| 每股收益（稀释后） | $-2.56 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $236.8M | $201.5M | ||
| Q3 25 | $250.1M | $216.0M | ||
| Q2 25 | $274.1M | $202.8M | ||
| Q1 25 | $293.4M | $190.5M | ||
| Q4 24 | $309.9M | $192.2M | ||
| Q3 24 | $315.1M | $210.3M | ||
| Q2 24 | $339.8M | $214.2M |
净利润CCRNROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-82.9M | $4.6M | ||
| Q3 25 | $-4.8M | $8.6M | ||
| Q2 25 | $-6.7M | $-73.6M | ||
| Q1 25 | $-490.0K | $-1.4M | ||
| Q4 24 | $-3.8M | $-500.0K | ||
| Q3 24 | $2.6M | $10.7M | ||
| Q2 24 | $-16.1M | $8.1M |
毛利率CCRNROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | 20.4% | 33.5% | ||
| Q2 25 | 20.4% | 31.6% | ||
| Q1 25 | 20.0% | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | 20.4% | 35.2% | ||
| Q2 24 | 20.8% | 34.1% |
营业利润率CCRNROG
| Q1 26 | — | — | ||
| Q4 25 | -30.2% | 3.5% | ||
| Q3 25 | -2.4% | 7.3% | ||
| Q2 25 | -2.1% | -33.3% | ||
| Q1 25 | -0.3% | -0.2% | ||
| Q4 24 | -1.1% | -6.6% | ||
| Q3 24 | 0.9% | 6.9% | ||
| Q2 24 | -5.7% | 5.3% |
净利率CCRNROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -35.0% | 2.3% | ||
| Q3 25 | -1.9% | 4.0% | ||
| Q2 25 | -2.4% | -36.3% | ||
| Q1 25 | -0.2% | -0.7% | ||
| Q4 24 | -1.2% | -0.3% | ||
| Q3 24 | 0.8% | 5.1% | ||
| Q2 24 | -4.7% | 3.8% |
每股收益（稀释后）CCRNROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-2.56 | $0.20 | ||
| Q3 25 | $-0.15 | $0.48 | ||
| Q2 25 | $-0.20 | $-4.00 | ||
| Q1 25 | $-0.02 | $-0.08 | ||
| Q4 24 | $-0.13 | $-0.04 | ||
| Q3 24 | $0.08 | $0.58 | ||
| Q2 24 | $-0.47 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $1.2B |
| 总资产 | $449.0M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $108.7M | $197.0M | ||
| Q3 25 | $99.1M | $167.8M | ||
| Q2 25 | $81.2M | $157.2M | ||
| Q1 25 | $80.7M | $175.6M | ||
| Q4 24 | $81.6M | $159.8M | ||
| Q3 24 | $64.0M | $146.4M | ||
| Q2 24 | $69.6M | $119.9M |
股东权益CCRNROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $322.8M | $1.2B | ||
| Q3 25 | $408.1M | $1.2B | ||
| Q2 25 | $412.2M | $1.2B | ||
| Q1 25 | $418.2M | $1.3B | ||
| Q4 24 | $419.0M | $1.3B | ||
| Q3 24 | $424.7M | $1.3B | ||
| Q2 24 | $433.3M | $1.3B |
总资产CCRNROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $449.0M | $1.4B | ||
| Q3 25 | $538.2M | $1.4B | ||
| Q2 25 | $553.8M | $1.5B | ||
| Q1 25 | $576.2M | $1.5B | ||
| Q4 24 | $589.3M | $1.5B | ||
| Q3 24 | $597.4M | $1.5B | ||
| Q2 24 | $602.9M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $1.1M |
| 自由现金流率自由现金流/营收 | 6.8% | 0.5% |
| 资本支出强度资本支出/营收 | 0.9% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $70.1M |
8季度趋势，按日历期对齐
经营现金流CCRNROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $18.2M | $46.9M | ||
| Q3 25 | $20.1M | $28.9M | ||
| Q2 25 | $4.2M | $13.7M | ||
| Q1 25 | $5.7M | $11.7M | ||
| Q4 24 | $24.2M | $33.7M | ||
| Q3 24 | $7.5M | $42.4M | ||
| Q2 24 | $82.4M | $22.9M |
自由现金流CCRNROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $16.1M | $42.2M | ||
| Q3 25 | $17.9M | $21.2M | ||
| Q2 25 | $2.3M | $5.6M | ||
| Q1 25 | $3.8M | $2.1M | ||
| Q4 24 | $21.7M | $18.3M | ||
| Q3 24 | $6.3M | $25.2M | ||
| Q2 24 | $79.6M | $8.8M |
自由现金流率CCRNROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 6.8% | 20.9% | ||
| Q3 25 | 7.2% | 9.8% | ||
| Q2 25 | 0.8% | 2.8% | ||
| Q1 25 | 1.3% | 1.1% | ||
| Q4 24 | 7.0% | 9.5% | ||
| Q3 24 | 2.0% | 12.0% | ||
| Q2 24 | 23.4% | 4.1% |
资本支出强度CCRNROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.9% | 2.3% | ||
| Q3 25 | 0.9% | 3.6% | ||
| Q2 25 | 0.7% | 4.0% | ||
| Q1 25 | 0.6% | 5.0% | ||
| Q4 24 | 0.8% | 8.0% | ||
| Q3 24 | 0.4% | 8.2% | ||
| Q2 24 | 0.8% | 6.6% |
现金转化率CCRNROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
ROG
暂无分部数据
